{"id":"W2138369468","doi":"10.1161/hc0802.104407","title":"Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2","year":2002,"lang":"en","type":"article","venue":"Circulation","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":650,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Angina; Placebo; Coronary artery disease; Cardiology; Internal medicine; Perfusion; Revascularization; Adverse effect; Multicenter trial; Randomized controlled trial; Myocardial infarction; Multicenter study; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005009295,0.0004024473,0.0006980135,0.0002144215,0.0001618526,0.0002393361,0.0003565054,0.000494035,0.001475876],"category_scores_gemma":[0.0005199664,0.0000891836,0.0003434616,0.0001943517,0.0003313551,0.0001329301,0.0001220323,0.0007944002,0.0002605605],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002126242,"about_ca_system_score_gemma":0.0001880508,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000205913,"about_ca_topic_score_gemma":0.0003870141,"domain_scores_codex":[0.9998341,0.0000641787,0.00001645873,0.00002568937,0.00003354228,0.00002606832],"domain_scores_gemma":[0.9998296,0.00005462034,0.0000574432,0.000006871782,0.000007812389,0.000043538],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1833687,0.02201916,0.02671006,0.006079034,0.002148811,0.0008628599,0.0001883776,0.001088675,0.2230019,0.0005361479,0.005894477,0.5281018],"study_design_scores_gemma":[0.3413147,0.4068139,0.1804992,0.0009337837,0.002382975,0.003516807,0.0001603149,0.001811064,0.04196204,0.0005577255,0.01998418,0.00006335966],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9462361,0.04770809,0.0009670393,0.0008406274,0.000259842,0.0005277136,0.0002362642,0.00009602335,0.003128123],"genre_scores_gemma":[0.9815011,0.01311627,0.001919209,0.0008773362,0.0008723587,0.0007318272,0.0004979807,0.000008096796,0.0004758372],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001475876,"threshold_uncertainty_score":0.004937291,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03233987525920993,"score_gpt":0.268180481859588,"score_spread":0.2358406066003781,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}